A260660 Stock Overview
Engages in the researches and develops, produces, and sells medicines in South Korea.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Korea Arlico Pharm Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩5,200.00 |
52 Week High | ₩7,480.00 |
52 Week Low | ₩4,320.00 |
Beta | 0.87 |
11 Month Change | 15.30% |
3 Month Change | 2.77% |
1 Year Change | -8.77% |
33 Year Change | -46.39% |
5 Year Change | 10.38% |
Change since IPO | -65.15% |
Recent News & Updates
Recent updates
There's Reason For Concern Over Korea Arlico Pharm Co.,Ltd.'s (KOSDAQ:260660) Price
Aug 04Is Korea Arlico PharmLtd (KOSDAQ:260660) Using Too Much Debt?
Mar 24Should You Be Adding Korea Arlico PharmLtd (KOSDAQ:260660) To Your Watchlist Today?
Mar 02Korea Arlico PharmLtd's (KOSDAQ:260660) Shareholders Are Down 50% On Their Shares
Feb 12What Is The Ownership Structure Like For Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)?
Jan 25Should You Use Korea Arlico PharmLtd's (KOSDAQ:260660) Statutory Earnings To Analyse It?
Jan 04Is Korea Arlico PharmLtd (KOSDAQ:260660) A Risky Investment?
Dec 16Are Strong Financial Prospects The Force That Is Driving The Momentum In Korea Arlico Pharm Co.,Ltd.'s KOSDAQ:260660) Stock?
Nov 25Shareholder Returns
A260660 | KR Pharmaceuticals | KR Market | |
---|---|---|---|
7D | 17.2% | -3.7% | -2.1% |
1Y | -8.8% | 5.2% | 0.3% |
Return vs Industry: A260660 underperformed the KR Pharmaceuticals industry which returned 5.2% over the past year.
Return vs Market: A260660 underperformed the KR Market which returned 0.3% over the past year.
Price Volatility
A260660 volatility | |
---|---|
A260660 Average Weekly Movement | 5.2% |
Pharmaceuticals Industry Average Movement | 4.4% |
Market Average Movement | 5.1% |
10% most volatile stocks in KR Market | 11.2% |
10% least volatile stocks in KR Market | 2.3% |
Stable Share Price: A260660 has not had significant price volatility in the past 3 months.
Volatility Over Time: A260660's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1992 | n/a | Hang-Gu Lee | www.arlico.co.kr |
Korea Arlico Pharm Co.,Ltd. engages in the researches and develops, produces, and sells medicines in South Korea. It offers ETC, OTC, medical device, and other products; and active ingredients.
Korea Arlico Pharm Co.,Ltd. Fundamentals Summary
A260660 fundamental statistics | |
---|---|
Market cap | ₩79.70b |
Earnings (TTM) | -₩1.37b |
Revenue (TTM) | ₩183.96b |
0.4x
P/S Ratio-58.2x
P/E RatioIs A260660 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A260660 income statement (TTM) | |
---|---|
Revenue | ₩183.96b |
Cost of Revenue | ₩78.84b |
Gross Profit | ₩105.12b |
Other Expenses | ₩106.49b |
Earnings | -₩1.37b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -89.34 |
Gross Margin | 57.14% |
Net Profit Margin | -0.74% |
Debt/Equity Ratio | 54.7% |
How did A260660 perform over the long term?
See historical performance and comparison